The purpose of this study was to evaluate the clinical characteristics of NSCLC patients to distinguish between ALK&ROS1 gene rearrangement, EGFR mutation, and non‐ALK&ROS1/EGFR mutation. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.